Investors dumped shares in pharmaceutical giant AstraZeneca as its biggest-selling drug failed to beat US rival Pfizer's product in head-to-head tests... more
Is the commodities boom petering out? Goldman Sachs reckons so, its prediction contributing to a drop in the price of oil and metals today as speculators pocketed profits... more
When drugs giant Pfizer announced it was pulling out of Sandwich in Kent recently there was shock. But does the US company's UK website provide a clue?... more
The UK's biggest privately-owned builder is expected to land a £400 million deal to build a laboratory dubbed a "cathedral for science" in central London... more
Politicians accuse the government of lacking a comprehensive growth strategy, saying the true test of a new agreement with banks would be whether it actually led to increased lending to businesses... more
Anyone know any billionaires? I'd love to meet Lakshmi Mittal..." London mother Sharmila Nikapota was not joking last week when she made a clarion call to London's super-rich at the Everyman Cinema to find a cure for her eight-year-old daughter Sohana's rare skin condition... more
Barely a month into a pivotal year for the economy, Chancellor George Osborne's refusal to even countenance a "plan B" on tackling the deficit is looking increasingly wobbly... more
Healthcare just might be the most undersung sector in the communications business. Tough regulations mean that it lacks the glamour of some other areas of marketing... more
It takes a real provocation to elicit a rebuke to London's Tory Mayor from a Tory assembly member. But Boris's plans to extend the Crossrail development tax has been attacked by a true-blue from the Transport Committee... more
Pfizer's plans to axe 2400 jobs in Sandwich are the latest blow to Britain's status as a world leader in pharmaceutical research and development... more
Drugs giant Pfizer's decision to close its leading UK research centre is "hugely worrying" for Britain, shadow business secretary John Denham warns
... more
The biggest job in the pharmaceuticals industry goes to a high-flying, London-educated Briton, Ian Read, who is the new chief executive of Pfizer, the world’s No. 1 drugmaker... more
How often have supposed shareholder revolts on directors' pay turned into a damp squib? Very. Much of the blame can be laid at the door of the institutional shareholders. ... more
Britain's biggest pharma firm GlaxoSmithKline joined with Viagra maker Pfizer to form an HIV drug company that will control almost a fifth of the $13 billion (£9 billion) HIV medicine market... more
Renewed fears about the financial sector hammered leading insurance groups, with investors increasingly worried about the insurance world's exposure to corporate debt, especially bank bonds. ... more
The government should offer tax incentives for the pharmaceutical industry to invest in biotechnology, a report produced under the umbrella of the UK's BioIndustry Association said... more
Credit crunch: The Freemans and Grattan catalogues, Barclays and Jaguar Land Rover all said thousands of jobs will be axed, bringing the total this week up to nearly 13,000... more
Analysis: The head of Pfizer, the world's largest drug company, this week set the pharmaceutical industry alight with talk of a megadeal when he revealed a shopping list of rivals in his sights... more
Health: Drug giants AstraZeneca and Pfizer have received a boost for their cholesterol-lowering medicines after a US report said they do not increase the risk of the neurological disorder known as Lou Gehrig's disease... more
Sound check: German industrial metal band Rammstein literally play with fire in their live performances - and now they are about to unleash their singeing spectacle on London. Watch out for your eyebrows
Morning:
6°c
